BlackRock Amends LH Stake: Passive Ownership Update
Ticker: LH · Form: SC 13G/A · Filed: Jan 30, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Laboratory Corp Of America Holdings (LH) |
| Form Type | SC 13G/A |
| Filed Date | Jan 30, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investing, amendment, healthcare
TL;DR
**BlackRock just updated its LabCorp (LH) stake, confirming continued passive ownership.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 30, 2024, disclosing its ownership in Laboratory Corporation of America Holdings (LH) as of December 31, 2023. This amendment, the 15th for BlackRock, indicates their continued significant, though slightly adjusted, passive stake in the medical diagnostics company. This matters to investors because BlackRock is a major institutional investor, and their holdings can signal confidence or a shift in sentiment towards LH, potentially influencing other investors and the stock's performance.
Why It Matters
BlackRock's updated filing provides transparency into its substantial, passive investment in LabCorp, offering a glimpse into a major institutional investor's position.
Risk Assessment
Risk Level: low — This filing is a routine update from a passive institutional investor and does not indicate any immediate significant risk or change in company operations.
Analyst Insight
Investors should note BlackRock's continued passive interest in LabCorp, but this filing alone doesn't suggest any immediate buy or sell action. It's a routine disclosure of a large institutional holding.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- LABORATORY CORPORATION OF AMERICA HOLDINGS (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 30, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Laboratory Corporation of America Holdings. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 15' in the filing.
Who is the 'subject company' whose shares are being reported?
The subject company is LABORATORY CORPORATION OF AMERICA HOLDINGS, identified by 'COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS' and CIK 0000920148.
Who is the 'reporting person' or entity that filed this document?
The reporting person is BlackRock Inc., identified by 'COMPANY CONFORMED NAME: BlackRock Inc.' and CIK 0001364742.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which required this filing was December 31, 2023, as stated in the filing under 'Date of Event Which Requires Filing of this Statement'.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)' in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 30, 2024 regarding LABORATORY CORP OF AMERICA HOLDINGS (LH).